Published in Curr Eye Res on July 10, 2013
Prophylactic Vancomycin Drops Reduce the Severity of Early Bacterial Keratitis in Keratoprosthesis. PLoS One (2015) 1.39
Neutrophil IL-1β processing induced by pneumolysin is mediated by the NLRP3/ASC inflammasome and caspase-1 activation and is dependent on K+ efflux. J Immunol (2015) 1.05
Microbiota-driven immune cellular maturation is essential for antibody-mediated adaptive immunity to Staphylococcus aureus infection in the eye. Infect Immun (2014) 0.88
TLR4 contributes to the host response to Klebsiella intraocular infection. Curr Eye Res (2014) 0.80
Unexpected Roles for Toll-Like Receptor 4 and TRIF in Intraocular Infection with Gram-Positive Bacteria. Infect Immun (2015) 0.77
Deformation of the lamina cribrosa and anterior scleral canal wall in early experimental glaucoma. Invest Ophthalmol Vis Sci (2003) 3.00
HSV-1 DNA in tears and saliva of normal adults. Invest Ophthalmol Vis Sci (2005) 2.13
The polycomb group protein Bmi1 binds to the herpes simplex virus 1 latent genome and maintains repressive histone marks during latency. J Virol (2009) 1.53
Coordinate activation of HIF-1 and NF-kappaB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia. Invest Ophthalmol Vis Sci (2003) 1.28
Clinician change detection viewing longitudinal stereophotographs compared to confocal scanning laser tomography in the LSU Experimental Glaucoma (LEG) Study. Ophthalmology (2002) 1.23
Effect of immunosuppression on gene expression in the HSV-1 latently infected mouse trigeminal ganglion. Invest Ophthalmol Vis Sci (2002) 1.21
The high prevalence of herpes simplex virus type 1 DNA in human trigeminal ganglia is not a function of age or gender. J Virol (2008) 1.19
Peripapillary scleral thickness in perfusion-fixed normal monkey eyes. Invest Ophthalmol Vis Sci (2002) 1.12
Rabbit and mouse models of HSV-1 latency, reactivation, and recurrent eye diseases. J Biomed Biotechnol (2012) 1.09
Effective treatment of ocular HSK with a human apolipoprotein E mimetic peptide in a mouse eye model. Invest Ophthalmol Vis Sci (2008) 1.07
Discovery of natural perchlorate in the Antarctic Dry Valleys and its global implications. Environ Sci Technol (2010) 1.02
Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis. Antimicrob Agents Chemother (2004) 1.01
Comparison of retinal outcomes after scleral buckle or lens-sparing vitrectomy for stage 4 retinopathy of prematurity. Retina (2004) 0.98
The region of the HSV-1 latency-associated transcript required for epinephrine-induced reactivation in the rabbit does not include the 2.0-kb intron. Virology (2002) 0.97
Corneal pathogenesis of Staphylococcus aureus strain Newman. Invest Ophthalmol Vis Sci (2002) 0.96
A framework for detecting glaucomatous progression in the optic nerve head of an eye using proper orthogonal decomposition. IEEE Trans Inf Technol Biomed (2009) 0.95
A double-blind placebo-controlled study to evaluate valacyclovir alone and with aspirin for asymptomatic HSV-1 DNA shedding in human tears and saliva. Invest Ophthalmol Vis Sci (2009) 0.94
Are release recommendations for NGRI acquittees informed by relevant data? Behav Sci Law (2007) 0.90
Effect of human apolipoprotein E genotype on the pathogenesis of experimental ocular HSV-1. Exp Eye Res (2008) 0.88
Ocular virulence of capsule-deficient streptococcus pneumoniae in a rabbit keratitis model. Invest Ophthalmol Vis Sci (2005) 0.88
Pseudomonas aeruginosa small protease (PASP), a keratitis virulence factor. Invest Ophthalmol Vis Sci (2013) 0.87
The Streptococcus pneumoniae capsule is required for full virulence in pneumococcal endophthalmitis. Invest Ophthalmol Vis Sci (2011) 0.87
Change detection in regional and volumetric disc parameters using longitudinal confocal scanning laser tomography. Ophthalmology (2002) 0.87
Protection from Streptococcus pneumoniae keratitis by passive immunization with pneumolysin antiserum. Invest Ophthalmol Vis Sci (2008) 0.86
Medical response to a nuclear detonation: creating a playbook for state and local planners and responders. Disaster Med Public Health Prep (2011) 0.85
Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida. Curr Eye Res (2007) 0.85
Molecular analysis of Pseudomonas aeruginosa protease IV expressed in Pseudomonas putida. Invest Ophthalmol Vis Sci (2003) 0.84
Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis. Invest Ophthalmol Vis Sci (2011) 0.84
Properties of PASP: a Pseudomonas protease capable of mediating corneal erosions. Invest Ophthalmol Vis Sci (2009) 0.83
Long-term study of accommodative esotropia. J AAPOS (2005) 0.83
A comparison of pneumolysin activity and concentration in vitro and in vivo in a rabbit endophthalmitis model. Clin Ophthalmol (2008) 0.83
Assessment of Streptococcus pneumoniae capsule in conjunctivitis and keratitis in vivo neuraminidase activity increases in nonencapsulated pneumococci following conjunctival infection. Curr Eye Res (2010) 0.83
Age-related differences in rabbits during experimental Staphylococcus aureus keratitis. Invest Ophthalmol Vis Sci (2007) 0.83
Long-term vision results measured with Teller Acuity Cards and a new Light Perception/Projection Scale after management of late stages of retinopathy of prematurity. Arch Ophthalmol (2003) 0.83
HSV-1 latent rabbits shed viral DNA into their saliva. Virol J (2012) 0.82
Efficacy of a helicase-primase inhibitor in animal models of ocular herpes simplex virus type 1 infection. J Ocul Pharmacol Ther (2008) 0.82
Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae Keratitis. Invest Ophthalmol Vis Sci (2011) 0.82
Long-term study of accommodative esotropia. Trans Am Ophthalmol Soc (2003) 0.82
Effect of high versus low oral doses of valacyclovir on herpes simplex virus-1 DNA shedding into tears of latently infected rabbits. Invest Ophthalmol Vis Sci (2010) 0.81
Pseudomonas aeruginosa protease IV: a corneal virulence factor of low immunogenicity. Ocul Immunol Inflamm (2005) 0.81
Localization of PcsB of Streptococcus pneumoniae and its differential expression in response to stress. J Bacteriol (2007) 0.80
"Boom" and "Bust" cycles in virus growth suggest multiple selective forces in influenza a evolution. Virol J (2011) 0.80
Variation in small bowel length: factor in achieving total enteroscopy? Dig Endosc (2014) 0.80
Immunization with pneumolysin protects against both retinal and global damage caused by Streptococcus pneumoniae endophthalmitis. J Ocul Pharmacol Ther (2010) 0.79
Development of a Streptococcus pneumoniae keratitis model in mice. Ophthalmic Res (2009) 0.79
The cholesterol-dependent cytolysin pneumolysin from Streptococcus pneumoniae binds to lipid raft microdomains in human corneal epithelial cells. PLoS One (2013) 0.79
Upregulation of mouse genes in HSV-1 latent TG after butyrate treatment implicates the multiple roles of the LAT-ICP0 locus. Invest Ophthalmol Vis Sci (2011) 0.78
Identification of the active site residues of Pseudomonas aeruginosa protease IV. Importance of enzyme activity in autoprocessing and activation. J Biol Chem (2002) 0.78
Pathogenesis of A Clinical Ocular Strain of Streptococcus pneumoniae and the Interaction of Pneumolysin with Corneal Cells. J Bacteriol Parasitol (2011) 0.78
Apolipoprotein E modulates establishment of HSV-1 latency and survival in a mouse ocular model. Curr Eye Res (2006) 0.78
Comparative efficacy of besifloxacin and other fluoroquinolones in a prophylaxis model of penicillin-resistant Streptococcus pneumoniae rabbit endophthalmitis. J Ocul Pharmacol Ther (2010) 0.77
Pathogenesis of Staphylococcus in the rabbit anterior chamber. Invest Ophthalmol Vis Sci (2005) 0.77
Moxifloxacin and cholesterol combined treatment of pneumococcal keratitis. Curr Eye Res (2010) 0.77
Protein structure classification based on conserved hydrophobic residues. IEEE/ACM Trans Comput Biol Bioinform (2009) 0.77
Bupropion (Zyban, Wellbutrin) inhibits nicotine-induced viral reactivation in herpes simplex virus type 1 latent rabbits. J Pharmacol Exp Ther (2004) 0.76
Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis. Cornea (2009) 0.76
Effective release of a broad spectrum antibiotic from elastin-like polypeptide-collagen composite. J Biomed Mater Res A (2014) 0.76
Efficacy of besifloxacin in an early treatment model of methicillin-resistant Staphylococcus aureus keratitis. J Ocul Pharmacol Ther (2010) 0.76
The effectiveness of lysostaphin therapy for experimental coagulase-negative Staphylococcus endophthalmitis. Curr Eye Res (2006) 0.76
Staphylococcus aureus infection of the rabbit cornea following topical administration. Curr Eye Res (2012) 0.76
Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis. Curr Eye Res (2004) 0.76
Passive immunization with Pneumovax® 23 and pneumolysin in combination with vancomycin for pneumococcal endophthalmitis. BMC Ophthalmol (2013) 0.75
Differential bacterial gene expression during experimental pneumococcal endophthalmitis. Ophthalmic Res (2015) 0.75
Using dependency/association rules to find indications for computed tomography in a head trauma dataset. Artif Intell Med (2002) 0.75
A nation prepared: inspiration in the face of tragedy. Disaster Med Public Health Prep (2007) 0.75
Analyzing data in which the outcome is time to an event part II: The presence of multiple covariates. Nutr Neurosci (2003) 0.75